| Primary |
| Pain |
14.3% |
| Influenza Like Illness |
10.7% |
| Bipolar Disorder |
7.1% |
| Cardiac Disorder |
7.1% |
| Constipation |
7.1% |
| Hypertension |
7.1% |
| Pain In Extremity |
7.1% |
| Anaemia |
3.6% |
| Anxiety Disorder |
3.6% |
| Embolism Arterial |
3.6% |
| Extrapyramidal Disorder |
3.6% |
| Hypothyroidism |
3.6% |
| Movement Disorder |
3.6% |
| Pneumonia Bacterial |
3.6% |
| Psychotic Disorder |
3.6% |
| Tachycardia |
3.6% |
| Thrombosis |
3.6% |
| Varicose Ulceration |
3.6% |
|
| Bacteraemia |
14.3% |
| Haematoma |
14.3% |
| Multi-organ Failure |
14.3% |
| Oropharyngeal Blistering |
14.3% |
| Pancytopenia |
14.3% |
| Pneumonia |
14.3% |
| Pregnancy |
14.3% |
|
| Secondary |
| Drug Use For Unknown Indication |
28.4% |
| Product Used For Unknown Indication |
24.2% |
| Pain |
9.3% |
| Hypertension |
6.1% |
| Rheumatoid Arthritis |
5.3% |
| Duodenal Ulcer |
4.0% |
| Essential Hypertension |
2.6% |
| Erysipelas |
2.2% |
| Prophylaxis |
2.0% |
| Back Pain |
1.8% |
| Haemolytic Uraemic Syndrome |
1.8% |
| Anxiety |
1.7% |
| Depression |
1.6% |
| Ill-defined Disorder |
1.6% |
| Atrial Fibrillation |
1.4% |
| Type 2 Diabetes Mellitus |
1.4% |
| Thrombosis Prophylaxis |
1.3% |
| Bipolar Disorder |
1.2% |
| Arthralgia |
1.1% |
| Hypercholesterolaemia |
1.1% |
|
| Hepatocellular Injury |
12.0% |
| Vomiting |
11.0% |
| Thrombocytopenia |
8.4% |
| Rash Maculo-papular |
6.3% |
| Neutropenia |
5.2% |
| Pyrexia |
5.2% |
| Toxic Skin Eruption |
5.2% |
| Wheezing |
5.2% |
| Renal Failure |
4.7% |
| Renal Failure Acute |
4.7% |
| Transaminases Increased |
4.2% |
| Toxic Epidermal Necrolysis |
3.7% |
| Cytolytic Hepatitis |
3.1% |
| International Normalised Ratio Increased |
3.1% |
| Leukopenia |
3.1% |
| Pancreatic Enzymes Increased |
3.1% |
| Reversible Posterior Leukoencephalopathy Syndrome |
3.1% |
| Weight Decreased |
3.1% |
| Acute Generalised Exanthematous Pustulosis |
2.6% |
| Hepatitis |
2.6% |
|
| Concomitant |
| Drug Use For Unknown Indication |
23.5% |
| Product Used For Unknown Indication |
20.2% |
| Pain |
10.7% |
| Prophylaxis |
7.7% |
| Hypertension |
6.3% |
| Rheumatoid Arthritis |
3.7% |
| Depression |
3.3% |
| Thrombosis Prophylaxis |
2.6% |
| Osteoporosis |
2.5% |
| Nausea |
2.2% |
| Breast Cancer |
2.0% |
| Multiple Myeloma |
2.0% |
| Hepatitis C |
2.0% |
| Insomnia |
1.9% |
| Diarrhoea |
1.8% |
| Atrial Fibrillation |
1.7% |
| Non-small Cell Lung Cancer |
1.6% |
| Constipation |
1.5% |
| Head And Neck Cancer |
1.5% |
| Essential Hypertension |
1.4% |
|
| Vomiting |
12.6% |
| Weight Decreased |
8.9% |
| Pyrexia |
8.2% |
| Thrombocytopenia |
8.2% |
| Somnolence |
7.2% |
| Renal Failure Acute |
6.2% |
| Renal Failure |
5.9% |
| Pulmonary Embolism |
4.5% |
| Malaise |
3.5% |
| Nausea |
3.5% |
| Pneumonia |
3.5% |
| Urinary Tract Infection |
3.5% |
| Neutropenia |
3.2% |
| Sepsis |
3.2% |
| Tachycardia |
3.2% |
| Septic Shock |
3.0% |
| Toxic Skin Eruption |
3.0% |
| Rash Maculo-papular |
2.9% |
| General Physical Health Deterioration |
2.7% |
| Pancytopenia |
2.7% |
|
| Interacting |
| Drug Use For Unknown Indication |
30.6% |
| Product Used For Unknown Indication |
9.3% |
| Pain |
8.3% |
| Acute Myocardial Infarction |
5.6% |
| Atrial Fibrillation |
5.6% |
| Bronchitis |
5.6% |
| Hip Arthroplasty |
5.6% |
| Prophylaxis |
5.6% |
| Essential Hypertension |
2.8% |
| Myocardial Ischaemia |
2.8% |
| Type 1 Diabetes Mellitus |
2.8% |
| Anxiety Disorder |
1.9% |
| Arthralgia |
1.9% |
| Constipation |
1.9% |
| Deep Vein Thrombosis |
1.9% |
| Dyslipidaemia |
1.9% |
| Dyspnoea |
1.9% |
| Epilepsy |
1.9% |
| Quadriplegia |
1.9% |
| Arterial Thrombosis |
0.9% |
|
| International Normalised Ratio Increased |
20.0% |
| Drug Interaction |
15.0% |
| Vomiting |
15.0% |
| Hepatitis |
10.0% |
| Occult Blood Positive |
10.0% |
| Fall |
5.0% |
| Malignant Neoplasm Progression |
5.0% |
| Overdose |
5.0% |
| Pneumonia Bacterial |
5.0% |
| Renal Failure Acute |
5.0% |
| Vertigo |
5.0% |
|
